Sun Pharmaceutical Industries Ltd. closed 13.85% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Sun Pharmaceutical Industries Ltd. closed 14.89% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. | Art Garfunkel is breaking the ...

“We are positive on these three stocks—Sun Pharma, Dr Reddy’s, and Lupin—despite the tariff announcements. India remains the ‘pharmacy of the world,’ and there’s no challenge to its ...

Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a small maker of generics into a global pharmaceutical giant with a revenue of $5.8 ...

Among pharma stocks, Sun Pharma and Lupin are expected to remain under the radar of Dalal Street observers. “We can even expect the high impact on Pharma industry. While specific tariff ...

Aurobindo Pharma followed with a 9.4 per cent rally, while Dr Reddy’s Laboratories surged 7 per cent to Rs 1,226.9. Lupin also gained nearly 7 per cent, touching Rs 2,149.2. Other notable gainers ...

Sun Pharmaceuticals led the gainers of Nifty 50 components to end 3.41 per cent positive at ₹1,772. The stock soared 6 per cent from the previous close to hit a high of ₹1,812.70.

Granules India, Lupin, Gland Pharma and Cipla fell 5-6 per cent. Sun Pharmaceutical Industries slipped 5 per cent while Dr Reddy's Labs was down 4 per cent. Speaking on Air Force One, Trump said ...

Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group ...

Sun Pharma share price has seen a 10% decline in year-to-date (YTD) performance and an 11% drop over the past six months.